Subscribe to our blog for updates.


By submitting this form, you are consenting to receive marketing emails from: Gilmartin Group, 60 E Sir Francis Drake Blvd., Larkspur, CA, 94939. You can revoke your consent to receive emails at any time by using the SafeUnsubscribe® link, found at the bottom of every email. Emails are serviced by Constant Contact
All
Investor Relations
Analyst Day
ESG Newsletter
Logistics
Investors
Capital Raising
Presentation
Messaging
Guidance & Metrics
News Entry
Fundraising
Earnings
COVID-19
Strategy
SPAC
IPO
ESG
Newsletter
Conferences
Analysts
image for Gilmartin ESG Newsletter January 2023

Gilmartin ESG Newsletter January 2023

January 25, 2023 | ESG, ESG Newsletter,

Welcome to the latest edition of Gilmartin Group’s ESG newsletter and our first release for 2023. With a special focus on the healthcare sector, this newsletter sheds light on the latest trends in the rapidly evolving ESG space, covering developments with companies, investors, regulators, and policymakers. In The Spotlight Republican U.S. politicians are continuing their […]

image for Key Sector Takeaways Out of JPM

Key Sector Takeaways Out of JPM

January 20, 2023 | Conferences, Investor Relations, Investors,

Last week was a welcomed return to the in-person J.P. Morgan Healthcare Conference held in San Francisco each January. The annual event reunited fervid participants and fostered meetings among investors, analysts, bankers and strategic corporate teams across both public and private clients. At Gilmartin, we see this conference as the first look into the upcoming […]

image for 4 Things to Look for at JPM 2023

4 Things to Look for at JPM 2023

January 6, 2023 | Conferences, Investor Relations, Investors,

After a two year COVID-related hiatus, healthcare executives, investors, research analysts, bankers, and venture capitalists are once again headed back to San Francisco to meet with corporate management teams and greet old friends. While COVID-19 has somewhat loosened its grip on the U.S., its repercussions are still being felt in every industry, especially healthcare. Throughout […]

image for 10 Tips for a Better J.P. Morgan Conference

10 Tips for a Better J.P. Morgan Conference

December 22, 2022 | Conferences, Investor Relations, Investors,

JP Morgan 2023 is right around the corner. Readjusting to attending the conference in-person can be a bit daunting. To help spark your muscle memory and prepare you for a successful conference, we’ve pulled together our top 10 tips & tricks to a better, more efficient and valuable JPM week. 1 | If you’re going […]

image for The Who & What of Investors | 2023 J.P. Morgan Conference & Beyond

The Who & What of Investors | 2023 J.P. Morgan Conference & Beyond

December 16, 2022 | Conferences, Investor Relations, Investors,

Traveling to investor conferences can be time consuming and exhausting. While management teams are often provided with schedules from the conference host and investor biographies from Gilmartin, a name and biography doesn’t always tell the complete story. Understanding the job function and responsibilities of the person you’re meeting with are critical pieces of information to […]

image for Webinar Recap: Creative Financing & Investor Sentiment for Biotechs

Webinar Recap: Creative Financing & Investor Sentiment for Biotechs

December 14, 2022 | Investor Relations, Investors, Capital Raising, Fundraising,

WATCH WEBINAR REPLAY The Biotech team at Gilmartin recently hosted a webinar with BTIG on Creative Financing and Investor Sentiment for Biotechs. The webinar featured a Q&A session that was joined by BTIG’s K.C. Stone (Managing Director, Head of Healthcare Investment Banking), Mikhail Keyserman (Managing Director, Healthcare Investment Banking) and Michael Karmiol (Managing Director & Head of Healthcare Equity Capital Markets). The […]

image for 5 Biotech Market Trends out of the Biocom California CFO Breakfast Panel

5 Biotech Market Trends out of the Biocom California CFO Breakfast Panel

October 28, 2022 | Investor Relations, Strategy, Capital Raising,

Biocom California recently hosted an in-person panel with three equity research analysts: Ritu Baral from Cowen, Laura Chico from Wedbush, and Josh Schimmer from Evercore. Moderated by NIRI San Diego chapter president Jason Spark, the panel discussed the current and future biotechnology climate for both public and private companies. Our top five takeaways are below: […]

image for Webinar Recap: Fidelity Management & Research Virtual Buy-Side Engagement Panel

Webinar Recap: Fidelity Management & Research Virtual Buy-Side Engagement Panel

October 14, 2022 | Investor Relations, Strategy, Capital Raising,

Fidelity recently hosted a webcast focused on engaging with investors. The panel featured a Q&A session with several portfolio managers and analysts who offered specific tips on what matters, what doesn’t and how to position yourself for success when interacting with the investment community broadly and with asset managers at Fidelity, specifically. Here are our […]

image for Keynote Recap: MedTech Financing in The Current Market

Keynote Recap: MedTech Financing in The Current Market

September 2, 2022 | Strategy, Capital Raising, Investor Relations,

In the event you missed it, Gilmartin held its Inaugural Emerging Growth Company Showcase featuring a Keynote Panel on MedTech Financing in The Current Market that was joined by Morgan Stanley’s Peter Harrison (Managing Director, Investment Banking), Piper Sandler’s Neil Riley (Managing Director, Equity Capital Markets), and Wilson Sonsini Goodrich & Rosati’s Philip Oettinger. The panel was moderated by Lynn Lewis (Founder & Chief […]

image for Financial Forecasting During a Period of Macro-Economic Uncertainty

Financial Forecasting During a Period of Macro-Economic Uncertainty

July 29, 2022 | Strategy, Investor Relations, Guidance & Metrics,

When investors evaluate investment opportunities, they look to management teams who accurately forecast and deliver results at or above guided levels. With macro-economic factors placing increasing pressure on financial results and expectations, it is as important as ever for companies to outline a plan they can confidently execute against. Generally, guidance metrics include top-line growth, […]

image for Mid-Year 2022 Private Market Review (VC) and Fundraising Refresher

Mid-Year 2022 Private Market Review (VC) and Fundraising Refresher

July 22, 2022 | Investors, Fundraising, News Entry,

The past few years have been ones of immense strength and record activity for venture capital (VC). Following a monstrous and record-setting 2021, the first half of 2022 has been different of sorts. VC has not been sheltered from the barrage of uncertainty felt in broader markets due to macro concerns. The private market has […]

image for Gilmartin Group ESG Newsletter June 2022 Newsletter

Gilmartin Group ESG Newsletter June 2022 Newsletter

June 30, 2022 | ESG, ESG Newsletter,

Welcome to the latest edition of Gilmartin Group’s ESG newsletter. With a special focus on the healthcare sector, this newsletter sheds light on the latest trends in the rapidly evolving ESG space, covering developments with companies, investors, regulators, and policymakers. IN THE SPOTLIGHT Over the past few years, ESG has grown increasingly mainstream within the […]

image for Common Questions Entering a Bear Market

Common Questions Entering a Bear Market

June 24, 2022 | Investors, Messaging, Strategy,

Coming off the heels of a record breaking 2021, the first half of 2022 has shaped up to be less than ideal. With no one key driver in our current climate, factors such as eastern unrest, high inflation and interest rates, supply chain complications, and labor challenges due to wage inflation have indicated a looming […]

image for The Return of In-Person Meetings

The Return of In-Person Meetings

June 10, 2022 | Investors, Conferences, Strategy,

As COVID-19 became widespread in early 2020, global gatherings came to a complete standstill, emptying sports stadiums, airports, and restaurants. Investor events were no exception, with many investment bank conferences and industry gatherings being outright cancelled or postponed during this time. Many executive teams concerned over the disruption of the pandemic on the market and […]

image for The Un-stealthing Process for Early-Stage Private Companies

The Un-stealthing Process for Early-Stage Private Companies

May 20, 2022 | Presentation, Messaging, Strategy,

For early-stage private healthcare companies, the process of un-stealthing is thematically similar to the process of becoming a publicly traded company; namely, the company has to prepare for increased scrutiny from external parties. Therefore, when making the decision to un-stealth, when and how to do so should be decided in the context of several important […]

image for How to Leverage Your IR Calendar for Success

How to Leverage Your IR Calendar for Success

May 13, 2022 | Strategy, Logistics, Investor Relations,

The IR calendar is a vital tool used by any investor relations professional. One of the most important aspects of IR is making sure that your management team is regularly in front of investors without limiting their ability to run their business. Ultimately, it is a delicate balance. The IR calendar allows the IR team, […]

image for How Public and Private Biotech Companies Should Utilize PR

How Public and Private Biotech Companies Should Utilize PR

May 6, 2022 | Strategy, Investor Relations,

Recently, the Gilmartin biotech team hosted a webinar with Berry and Company, discussing how public and private biotechnology companies should utilize public relations (PR). If you were unable to attend, you can watch a replay of the conversation. Gilmartin Group’s managing director Laurence Watts and principal biotech Stephen Jasper interviewed Berry and Company’s Bill Berry, […]

image for MedTech Research Coverage: Who Covers Whom?

MedTech Research Coverage: Who Covers Whom?

April 29, 2022 | Earnings, Analysts, Strategy,

While it may be easy to feel content with coverage from your group of supportive sell-side analysts, it is important to consider how this list will evolve throughout the lifespan of your company. For some public issuers, this will happen naturally, but others may need to take a more active approach to keep their sell-side […]

image for Understanding Short Interest for Recent IPO’s

Understanding Short Interest for Recent IPO’s

April 22, 2022 | Strategy, IPO, Guidance & Metrics,

It is no secret that newly listed companies face a host of issues that many established public companies do not face. Whether it be a lack of executional credibility or liquidity issues caused by the lock-up period, management teams are often fighting an uphill battle during the early days of being a newly public company. […]

image for Gilmartin Group ESG Newsletter 3

Gilmartin Group ESG Newsletter 3

April 19, 2022 | ESG Newsletter, ESG,

Welcome to the latest edition of Gilmartin Group’s ESG newsletter. With a special focus on the healthcare sector, this newsletter sheds light on the latest trends in the rapidly evolving ESG space, covering developments with companies, investors, regulators, and policymakers. IN THE SPOTLIGHT In late March, the SEC proposed a set of rules that would […]

image for Impacts of Labor Dynamics on Hospital Finances and the Healthcare Industry

Impacts of Labor Dynamics on Hospital Finances and the Healthcare Industry

April 1, 2022 | Strategy, Messaging, Logistics,

Labor—salaries and wages for physicians, nurses, and other healthcare professionals—has historically represented a significant portion of hospitals’ operating expenses. For HCA Healthcare, one of the largest healthcare systems in the US, the ratio of salaries and benefits expenses to revenues consistently approximated 46% from 2019-2021. By comparison, supplies as a percent of revenues approximated 16% […]

image for Recap of Webinar: Demystifying ESG Reporting for Healthcare Companies

Recap of Webinar: Demystifying ESG Reporting for Healthcare Companies

March 25, 2022 | Strategy, Investor Relations, ESG,

On March 17, 2022, the Gilmartin ESG team hosted a webinar with a panel of leaders from three healthcare companies that have integrated ESG into their decision-making and reporting processes. If you were unable to attend, you can watch a replay of the conversation. Matt Berner, Managing Director of ESG Advisory at Gilmartin Group, and […]

image for How to Navigate Clinical Development Setbacks

How to Navigate Clinical Development Setbacks

March 18, 2022 | Strategy, Messaging, Investor Relations,

Understanding the challenges biotech companies face when developing drugs is vital to assessing risk factors that might hinder a company’s clinical trial program. First, the probability of success is low; approximately 1 in 1,000 potential drugs graduate to human clinical trials after the preclinical testing phase in the United States and almost 9 of every […]

image for Recap of Webinar: Debt Financing for Emerging Biotechs

Recap of Webinar: Debt Financing for Emerging Biotechs

February 25, 2022 | Strategy, Capital Raising,

Recently, the Gilmartin biotech team hosted a webinar with Silicon Valley Bank (SVB), discussing debt financing for emerging biotech companies. If you were unable to attend, you can watch a replay of the conversation. Gilmartin Group’s managing director Laurence Watts and principal biotech Stephen Jasper interviewed SVB’s managing directors Kate Walsh and Shawn Perry about […]

image for Ins and Outs of “Down Rounds”

Ins and Outs of “Down Rounds”

February 11, 2022 | Investor Relations, Strategy, Investors,

What is a “down round” and why would a company settle for these financing terms? To fully comprehend the circumstances that might lead to a down round, one first needs to grasp how private companies grow. Typically, they will raise capital through equity financing events (known as rounds), in which shares of the company are […]

image for Gilmartin Group ESG Newsletter February 2022

Gilmartin Group ESG Newsletter February 2022

February 8, 2022 | ESG, ESG Newsletter,

Welcome to the latest edition of Gilmartin Group’s ESG newsletter and our first update for 2022. With a special focus on the healthcare sector, this newsletter sheds light on the latest trends in the rapidly evolving ESG space, covering developments with companies, investors, regulators, and policymakers. IN THE SPOTLIGHT Hologic started the new year with […]

image for 3 Advancements in Oncology for 2022

3 Advancements in Oncology for 2022

February 4, 2022 | Messaging, Investor Relations, Strategy,

As we enter 2022, a new year, it is common to find ourselves full of hopefulness for the future. As we leave last year behind, we may also find ourselves reflecting on the past. Since 1933, cancer has held the position of the second leading cause of death in the U.S. As predicted by the […]

image for Gilmartin Group ESG Newsletter November 2021

Gilmartin Group ESG Newsletter November 2021

November 23, 2021 | ESG, ESG Newsletter,

Welcome to Gilmartin’s inaugural ESG newsletter. With a special focus on the healthcare sector, this newsletter sheds light on the latest trends in the rapidly evolving ESG space, covering developments with companies, investors, regulators, and policymakers. If you want to learn more about ESG, contact the Gilmartin ESG team. IN THE SPOTLIGHT Medtronic released its […]

image for The Rising Costs of National Healthcare

The Rising Costs of National Healthcare

November 19, 2021 | Messaging, Investor Relations, Strategy,

[fusion_builder_container hundred_percent=”no” equal_height_columns=”no” hide_on_mobile=”small-visibility,medium-visibility,large-visibility” background_position=”center center” background_repeat=”no-repeat” fade=”no” background_parallax=”none” parallax_speed=”0.3″ video_aspect_ratio=”16:9″ video_loop=”yes” video_mute=”yes” border_style=”solid” type=”legacy”][fusion_builder_row][fusion_builder_column type=”1_1″ layout=”1_1″ background_position=”left top” background_color=”” border_color=”” border_style=”solid” border_position=”all” spacing=”yes” background_image=”” background_repeat=”no-repeat” padding_top=”” padding_right=”” padding_bottom=”” padding_left=”” margin_top=”0px” margin_bottom=”0px” class=”” id=”” animation_type=”” animation_speed=”0.3″ animation_direction=”left” hide_on_mobile=”small-visibility,medium-visibility,large-visibility” center_content=”no” last=”true” min_height=”” hover_type=”none” link=”” first=”true” border_sizes_top=”” border_sizes_bottom=”” border_sizes_left=”” border_sizes_right=””][fusion_text columns=”” column_min_width=”” column_spacing=”” rule_style=”default” rule_size=”” rule_color=”” content_alignment_medium=”” […]

image for The Makings of a Successful Crossover Round in Biotech

The Makings of a Successful Crossover Round in Biotech

November 12, 2021 | Investor Relations, Strategy, Investors,

[fusion_builder_container hundred_percent=”no” equal_height_columns=”no” hide_on_mobile=”small-visibility,medium-visibility,large-visibility” background_position=”center center” background_repeat=”no-repeat” fade=”no” background_parallax=”none” parallax_speed=”0.3″ video_aspect_ratio=”16:9″ video_loop=”yes” video_mute=”yes” border_style=”solid” type=”legacy”][fusion_builder_row][fusion_builder_column type=”1_1″ layout=”1_1″ background_position=”left top” background_color=”” border_color=”” border_style=”solid” border_position=”all” spacing=”yes” background_image=”” background_repeat=”no-repeat” padding_top=”” padding_right=”” padding_bottom=”” padding_left=”” margin_top=”0px” margin_bottom=”0px” class=”” id=”” animation_type=”” animation_speed=”0.3″ animation_direction=”left” hide_on_mobile=”small-visibility,medium-visibility,large-visibility” center_content=”no” last=”true” min_height=”” hover_type=”none” link=”” first=”true” border_sizes_top=”” border_sizes_bottom=”” border_sizes_left=”” border_sizes_right=””][fusion_text columns=”” column_min_width=”” column_spacing=”” rule_style=”default” rule_size=”” rule_color=”” content_alignment_medium=”” […]

image for A New Legacy: The Shifting Investment Landscape of Family Offices

A New Legacy: The Shifting Investment Landscape of Family Offices

October 29, 2021 | Investor Relations, Strategy, Investors,

Family offices around the world have become increasingly active and sophisticated in their investment into innovations over the years. The growth of family offices and their broadened investment mandates have led to an expanding influence in venture capital and private equity. While the spotlight on investment capital has often focused on more traditional sources (i.e., […]

image for The SASB Standards: An Overview for the Healthcare Sector

The SASB Standards: An Overview for the Healthcare Sector

October 22, 2021 | Strategy, ESG, Investor Relations,

With the rise of ESG integration across capital markets, investors are looking beyond traditional financial statements to understand how sustainability issues impact enterprise value. While companies are expected to disclose more ESG-related information than ever before, disclosures currently lack the standardization of financial statements. In the U.S., the SEC requires companies to report financial information […]

image for How the $3.5T Federal Spending Package May Impact the Healthcare Industry

How the $3.5T Federal Spending Package May Impact the Healthcare Industry

September 17, 2021 | Strategy, ESG, Investor Relations,

After almost two years of near constant twists and turns through the COVID-era, the fiscal roller coaster ride isn’t over yet. As the House gears up to jockey over final details of the $1T spending bill passed by the Senate in early August, eyes are already turning towards the $3.5T package that is expected to […]

image for Dual Listings: Considerations and Processes to Ensure Success

Dual Listings: Considerations and Processes to Ensure Success

September 10, 2021 | Strategy, ESG, Investor Relations,

It’s approaching dawn in New York. We’re keeping a watchful eye on trading, as our market in the East has opened, trying to get a sense for how the US market will react when it too opens for trading. Earlier, we had ushered in a press release, with the timing of issuance earmarked to serve […]

image for A New Era of ESG – Environmental, Social, and Governance

A New Era of ESG – Environmental, Social, and Governance

August 13, 2021 | Strategy, ESG, Investor Relations,

2020 was a transformative year in recent history, and it also marked a pivotal year for ESG. Between the COVID-19 pandemic that upended the world, the swell of activism over social injustice, rising populism and political polarization, and the increasing occurrence of natural disasters linked to climate change, the events of 2020 warranted a major […]

image for Considerations of a SPAC: Part III – Takeaways from a Dozen Healthcare SPAC Processes

Considerations of a SPAC: Part III – Takeaways from a Dozen Healthcare SPAC Processes

July 30, 2021 | SPAC, Investor Relations, IPO,

Given the prevalence of recent SPAC-sponsored public listings, the process of executing a successful SPAC combination may seem clearer than ever. Advantages of combining with an SPAC (Special Purpose Acquisition Company, or blank-check company) are now relatively well understood, including (1) efficient access to capital and (2) the potential to leverage your SPAC partner for […]

image for A Beginner’s Guide to Non-Deal Roadshows

A Beginner’s Guide to Non-Deal Roadshows

July 23, 2021 | Strategy, Analysts, IPO,

Non-deal roadshows (NDRs) offer investors a comprehensive look at a company’s story that press releases, conference presentations, and other public documents cannot. Public and private companies alike may benefit from scheduling NDRs to foster effective communication between the executive team and investors. The focus of NDRs is to update investors on company performance (i.e. financial […]

image for Leveraging KOLs and PIs for Investor and Analyst Diligence

Leveraging KOLs and PIs for Investor and Analyst Diligence

July 9, 2021 | Strategy, Analysts, IPO,

Before investing in or launching coverage on a company, investors and analysts will want to perform rigorous due diligence. The ability to leverage primary research can go a long way. Key opinion leaders (KOLs) and primary investigators (PIs) are key assets in this area and can play an important role in educating the overall investment […]

image for Recap of Webinar: “How to Engage with Sell Side Analysts”

Recap of Webinar: “How to Engage with Sell Side Analysts”

June 18, 2021 | Messaging, Analysts, Strategy,

[fusion_builder_container hundred_percent=”no” equal_height_columns=”no” hide_on_mobile=”small-visibility,medium-visibility,large-visibility” background_position=”center center” background_repeat=”no-repeat” fade=”no” background_parallax=”none” parallax_speed=”0.3″ video_aspect_ratio=”16:9″ video_loop=”yes” video_mute=”yes” border_style=”solid” type=”legacy”][fusion_builder_row][fusion_builder_column type=”1_1″ layout=”1_1″ background_position=”left top” background_color=”” border_color=”” border_style=”solid” border_position=”all” spacing=”yes” background_image=”” background_repeat=”no-repeat” padding_top=”” padding_right=”” padding_bottom=”” padding_left=”” margin_top=”0px” margin_bottom=”0px” class=”” id=”” animation_type=”” animation_speed=”0.3″ animation_direction=”left” hide_on_mobile=”small-visibility,medium-visibility,large-visibility” center_content=”no” last=”true” min_height=”” hover_type=”none” link=”” first=”true” border_sizes_top=”” border_sizes_bottom=”” border_sizes_left=”” border_sizes_right=””][fusion_text columns=”” column_min_width=”” column_spacing=”” rule_style=”default” rule_size=”” rule_color=”” content_alignment_medium=”” […]

image for Maintaining Investor Trust and Shareholder Value Through a CEO Transition

Maintaining Investor Trust and Shareholder Value Through a CEO Transition

June 11, 2021 | Messaging, Investor Relations, Strategy,

When evaluating any company, investors look to the CEO for guidance, as CEOs are the bridge to the Street. As the face of the company, the CEO has to earn the trust of investors, customers, and employees. Therefore, the CEO’s role is heavily weighted when considering a potential investment. Inevitably, every company reaches an inflection […]

image for Gilmartin Pizza Review

Gilmartin Pizza Review

June 4, 2021 | News Entry,

Earlier this year, we published our first ever Gilmartin Book Review to kick off 2021 on a lighter note. It was so well received that we decided to start our summer off on the right foot with a “Gilmartin Pizza Review.” Originally, this conversation was sparked in an internal weekly meeting between two NYC pizza […]

image for Tips & Tricks for a Smoother Earnings Report

Tips & Tricks for a Smoother Earnings Report

May 28, 2021 | Earnings, Investor Relations, Strategy,

[fusion_builder_container hundred_percent=”no” equal_height_columns=”no” hide_on_mobile=”small-visibility,medium-visibility,large-visibility” background_position=”center center” background_repeat=”no-repeat” fade=”no” background_parallax=”none” parallax_speed=”0.3″ video_aspect_ratio=”16:9″ video_loop=”yes” video_mute=”yes” border_style=”solid” type=”legacy”][fusion_builder_row][fusion_builder_column type=”1_1″ layout=”1_1″ background_position=”left top” background_color=”” border_color=”” border_style=”solid” border_position=”all” spacing=”yes” background_image=”” background_repeat=”no-repeat” padding_top=”” padding_right=”” padding_bottom=”” padding_left=”” margin_top=”0px” margin_bottom=”0px” class=”” id=”” animation_type=”” animation_speed=”0.3″ animation_direction=”left” hide_on_mobile=”small-visibility,medium-visibility,large-visibility” center_content=”no” last=”true” min_height=”” hover_type=”none” link=”” first=”true” border_sizes_top=”” border_sizes_bottom=”” border_sizes_left=”” border_sizes_right=””][fusion_text columns=”” column_min_width=”” column_spacing=”” rule_style=”default” rule_size=”” rule_color=”” content_alignment_medium=”” […]

image for Material Non-Public Information (MNPI) & Insider Trading – The Basics

Material Non-Public Information (MNPI) & Insider Trading – The Basics

May 7, 2021 | Investor Relations, IPO, Strategy,

Disseminating information to employees on the IPO is an important step in becoming a public company. As we have discussed before, there are certain topics that are critical to discuss with employees, including Regulation FD (Reg FD), insider trading, material non-public information (MNPI), and employee stock plans. Today, let’s go through the basics of insider […]

image for Gene Editing – The 21st Century Miracle

Gene Editing – The 21st Century Miracle

April 30, 2021 | Investor Relations, IPO, Strategy,

Gene editing? CRISPR? Everyone has heard the term CRISPR from mainstream media. But few can explain what it is or its significance for the future of human medicine. Hailed as a 21st century miracle, Jennifer Doudna and Emmanuelle Charpentier were recently awarded the Nobel Prize for their breakthrough research on CRISPR technology in December 2020. […]

image for Addressing Unfavorable or Undesired Analyst Coverage

Addressing Unfavorable or Undesired Analyst Coverage

April 2, 2021 | Analysts, Investor Relations, Strategy,

Addressing Sell-Side Research Challenges: What to do When Your Company is Faced with Unfavorable or Inaccurate Analyst Coverage At the top of almost any IR to do list, and certainly one of the more important metrics used to evaluate a successful program, is sell-side analyst research coverage – particularly as it relates to quality banks, […]

image for The Telehealth Upward Trend

The Telehealth Upward Trend

March 26, 2021 | Investor Relations, Strategy,

[fusion_builder_container hundred_percent=”no” equal_height_columns=”no” hide_on_mobile=”small-visibility,medium-visibility,large-visibility” background_position=”center center” background_repeat=”no-repeat” fade=”no” background_parallax=”none” parallax_speed=”0.3″ video_aspect_ratio=”16:9″ video_loop=”yes” video_mute=”yes” border_style=”solid” type=”legacy”][fusion_builder_row][fusion_builder_column type=”1_1″ layout=”1_1″ background_position=”left top” background_color=”” border_color=”” border_style=”solid” border_position=”all” spacing=”yes” background_image=”” background_repeat=”no-repeat” padding_top=”” padding_right=”” padding_bottom=”” padding_left=”” margin_top=”0px” margin_bottom=”0px” class=”” id=”” animation_type=”” animation_speed=”0.3″ animation_direction=”left” hide_on_mobile=”small-visibility,medium-visibility,large-visibility” center_content=”no” last=”true” min_height=”” hover_type=”none” link=”” first=”true” border_sizes_top=”” border_sizes_bottom=”” border_sizes_left=”” border_sizes_right=””][fusion_text columns=”” column_min_width=”” column_spacing=”” rule_style=”default” rule_size=”” rule_color=”” content_alignment_medium=”” […]

image for How COVID-19 Continues to Affect Earnings

How COVID-19 Continues to Affect Earnings

March 19, 2021 | Earnings, Strategy, Investor Relations,

Twelve months ago, society as we knew it changed forever at the hands of the COVID-19 pandemic. As a result of this increased volatility and certain negative impact on health care systems and the global economy, public company executives had no choice but to withdraw 2020 financial guidance. This led investors to ask tough questions […]

image for Reinstating Guidance for 2021

Reinstating Guidance for 2021

March 5, 2021 | Earnings, Strategy, Investor Relations,

[fusion_builder_container hundred_percent=”no” equal_height_columns=”no” hide_on_mobile=”small-visibility,medium-visibility,large-visibility” background_position=”center center” background_repeat=”no-repeat” fade=”no” background_parallax=”none” parallax_speed=”0.3″ video_aspect_ratio=”16:9″ video_loop=”yes” video_mute=”yes” border_style=”solid” type=”legacy”][fusion_builder_row][fusion_builder_column type=”1_1″ layout=”1_1″ background_position=”left top” background_color=”” border_color=”” border_style=”solid” border_position=”all” spacing=”yes” background_image=”” background_repeat=”no-repeat” padding_top=”” padding_right=”” padding_bottom=”” padding_left=”” margin_top=”0px” margin_bottom=”0px” class=”” id=”” animation_type=”” animation_speed=”0.3″ animation_direction=”left” hide_on_mobile=”small-visibility,medium-visibility,large-visibility” center_content=”no” last=”true” min_height=”” hover_type=”none” link=”” first=”true” border_sizes_top=”” border_sizes_bottom=”” border_sizes_left=”” border_sizes_right=””][fusion_text columns=”” column_min_width=”” column_spacing=”” rule_style=”default” rule_size=”” rule_color=”” content_alignment_medium=”” […]

image for Disseminating Information to Employees on Your IPO

Disseminating Information to Employees on Your IPO

February 26, 2021 | Strategy, IPO, Investor Relations,

While transitioning to become a public company is a significant milestone in the corporate journey, moving forward toward this achievement, executives and employees face limitations around communications, along with an increased level of scrutiny by the SEC. Given these restrictions and heightened level of review, it is important for companies to implement a structured and […]

image for Ignore the Noise

Ignore the Noise

February 12, 2021 | Investor Relations, Investors, Strategy,

In his famous December 5, 1996 speech, former Federal Reserve Chairman Alan Greenspan stated, “But how do we know when irrational excitement has unduly escalated asset values, which then become subject to unexpected and prolonged contractions as they have in Japan over the past decade? And how do we factor that assessment into monetary policy?” […]

image for Activist Investors

Activist Investors

February 5, 2021 | Investor Relations, Investors, Strategy,

There are many benefits to becoming a public company; however, the additional publicity does not come without risks. Suddenly, investors have access to buy and sell shares of your company on a day-to-day basis, and the control over the top owners of your company diminishes. The substantial amount of capital investors put into your business […]

image for Early 2021 Trends and 2020 in Blogs

Early 2021 Trends and 2020 in Blogs

January 29, 2021 | IPO, Investor Relations, Investors,

Retail Momentum Market participant demographics are changing as new brokerage platforms like Robinhood, which offers convenient mobile apps and low commission trading, continue to attract the next generation of investors. This group is more engaged across social media, where “influencers” have demonstrated the ability to incite herd mentality trades that can generate meaningful momentum and […]

image for The Purpose and Goals of Testing The Waters Meetings

The Purpose and Goals of Testing The Waters Meetings

January 22, 2021 | IPO, Investor Relations, Investors,

[fusion_builder_container hundred_percent=”no” equal_height_columns=”no” menu_anchor=”” hide_on_mobile=”small-visibility,medium-visibility,large-visibility” class=”” id=”” background_color=”” background_image=”” background_position=”center center” background_repeat=”no-repeat” fade=”no” background_parallax=”none” parallax_speed=”0.3″ video_mp4=”” video_webm=”” video_ogv=”” video_url=”” video_aspect_ratio=”16:9″ video_loop=”yes” video_mute=”yes” overlay_color=”” video_preview_image=”” border_color=”” border_style=”solid” padding_top=”” padding_bottom=”” padding_left=”” padding_right=”” type=”legacy”][fusion_builder_row][fusion_builder_column type=”1_1″ layout=”1_1″ background_position=”left top” background_color=”” border_color=”” border_style=”solid” border_position=”all” spacing=”yes” background_image=”” background_repeat=”no-repeat” padding_top=”” padding_right=”” padding_bottom=”” padding_left=”” margin_top=”0px” margin_bottom=”0px” class=”” id=”” animation_type=”” animation_speed=”0.3″ animation_direction=”left” hide_on_mobile=”small-visibility,medium-visibility,large-visibility” center_content=”no” […]

image for Gilmartin’s 2021 Reading List

Gilmartin’s 2021 Reading List

January 15, 2021 | News Entry,

2020 brought a number of topics and trends to light within the healthcare sector, in which many of our peers have faced significant challenges throughout the year. We have addressed many of the topics in our blog throughout the course of the year. Some of the recurring topics included: What goes into a SPAC process; […]

image for Employee Sales on First Day of Trading

Employee Sales on First Day of Trading

December 18, 2020 | Investor Relations, Strategy, IPO,

Should Employees be Allowed to Sell Shares on the First Day of Trading? Airbnb’s IPO Pop: Auction Transparency, Public Market Appetite & Equity Compensation The first day of trading, when a newly minted public company begins to trade on the exchange, is a day marked with excitement and accomplishment.  It is a day of celebration, […]

image for Board Diversity and Wall Street – An Emerging Priority

Board Diversity and Wall Street – An Emerging Priority

December 11, 2020 | Investor Relations, Guidance & Metrics, Messaging,

Over the past year, Wall Street has increased its focus on diversity and its implications for companies. This discussion is reflective of not only a broader national dialogue on social justice, but also an international emphasis on Environmental, Social, and Corporate Governance (ESG) investing. While European-based funds have thought about socially responsible investing for quite […]

image for Maximizing Presentations & Investor Meetings in the 2021 Virtual Conference World

Maximizing Presentations & Investor Meetings in the 2021 Virtual Conference World

December 4, 2020 | Conferences, Investors, Strategy,

As 2020 mercifully heads to the rearview mirror, it does appear that the virtual conference scene is likely here for at least the first half of 2021. Depending on the pacing of the vaccine rollouts, it may potentially stay until the fall of next year.  With that in mind, managing the ever-shortening time slots at […]

image for Intro to Quarterly Financial Reporting

Intro to Quarterly Financial Reporting

November 20, 2020 | Analysts, Earnings,

There are many decisions that must be made before every company’s earning call. Every company will have its own correct answer based on the past working experience and comfort level of the management team presenting. A few of themost commonly asked questions are: Do we prepare slides for our quarterly call? Do we really need […]

image for What to Consider When Providing KPIs Post IPO

What to Consider When Providing KPIs Post IPO

November 6, 2020 | Investor Relations, Guidance & Metrics, Messaging, IPO,

[fusion_builder_container hundred_percent=”no” equal_height_columns=”no” menu_anchor=”” hide_on_mobile=”small-visibility,medium-visibility,large-visibility” class=”” id=”” background_color=”” background_image=”” background_position=”center center” background_repeat=”no-repeat” fade=”no” background_parallax=”none” parallax_speed=”0.3″ video_mp4=”” video_webm=”” video_ogv=”” video_url=”” video_aspect_ratio=”16:9″ video_loop=”yes” video_mute=”yes” overlay_color=”” video_preview_image=”” border_size=”” border_color=”” border_style=”solid” padding_top=”” padding_bottom=”” padding_left=”” padding_right=””][fusion_builder_row][fusion_builder_column type=”1_1″ layout=”1_1″ background_position=”left top” background_color=”” border_size=”” border_color=”” border_style=”solid” border_position=”all” spacing=”yes” background_image=”” background_repeat=”no-repeat” padding_top=”” padding_right=”” padding_bottom=”” padding_left=”” margin_top=”0px” margin_bottom=”0px” class=”” id=”” animation_type=”” animation_speed=”0.3″ animation_direction=”left” hide_on_mobile=”small-visibility,medium-visibility,large-visibility” […]

image for Director & Officer (D&O) Insurance for an IPO

Director & Officer (D&O) Insurance for an IPO

October 30, 2020 | IPO, Investor Relations,

Becoming a public company brings many benefits, including greater access to capital markets, additional publicity, and, of course, new cash to develop the business. However, an IPO also creates additional risks, particularly the risk of a class action lawsuit brought by investors following the IPO. One of the ways newly public companies can mitigate this […]

image for The Value Of Emergency INDs To Biotech Investors

The Value Of Emergency INDs To Biotech Investors

October 23, 2020 | Strategy, Investor Relations,

[fusion_builder_container hundred_percent=”no” equal_height_columns=”no” menu_anchor=”” hide_on_mobile=”small-visibility,medium-visibility,large-visibility” class=”” id=”” background_color=”” background_image=”” background_position=”center center” background_repeat=”no-repeat” fade=”no” background_parallax=”none” parallax_speed=”0.3″ video_mp4=”” video_webm=”” video_ogv=”” video_url=”” video_aspect_ratio=”16:9″ video_loop=”yes” video_mute=”yes” overlay_color=”” video_preview_image=”” border_size=”” border_color=”” border_style=”solid” padding_top=”” padding_bottom=”” padding_left=”” padding_right=””][fusion_builder_row][fusion_builder_column type=”1_1″ layout=”1_1″ background_position=”left top” background_color=”” border_size=”” border_color=”” border_style=”solid” border_position=”all” spacing=”yes” background_image=”” background_repeat=”no-repeat” padding_top=”” padding_right=”” padding_bottom=”” padding_left=”” margin_top=”0px” margin_bottom=”0px” class=”” id=”” animation_type=”” animation_speed=”0.3″ animation_direction=”left” hide_on_mobile=”small-visibility,medium-visibility,large-visibility” […]

image for Virtual Marketing Learnings

Virtual Marketing Learnings

October 2, 2020 | Presentation, Logistics, Investor Relations,

[fusion_builder_container hundred_percent=”no” equal_height_columns=”no” menu_anchor=”” hide_on_mobile=”small-visibility,medium-visibility,large-visibility” class=”” id=”” background_color=”” background_image=”” background_position=”center center” background_repeat=”no-repeat” fade=”no” background_parallax=”none” parallax_speed=”0.3″ video_mp4=”” video_webm=”” video_ogv=”” video_url=”” video_aspect_ratio=”16:9″ video_loop=”yes” video_mute=”yes” overlay_color=”” video_preview_image=”” border_size=”” border_color=”” border_style=”solid” padding_top=”” padding_bottom=”” padding_left=”” padding_right=””][fusion_builder_row][fusion_builder_column type=”1_1″ layout=”1_1″ background_position=”left top” background_color=”” border_size=”” border_color=”” border_style=”solid” border_position=”all” spacing=”yes” background_image=”” background_repeat=”no-repeat” padding_top=”” padding_right=”” padding_bottom=”” padding_left=”” margin_top=”0px” margin_bottom=”0px” class=”” id=”” animation_type=”” animation_speed=”0.3″ animation_direction=”left” hide_on_mobile=”small-visibility,medium-visibility,large-visibility” […]

image for The SEC’s Proposed 13F Reform and its Implications on Public Issuers

The SEC’s Proposed 13F Reform and its Implications on Public Issuers

September 24, 2020 | Investors, Investor Relations,

[fusion_builder_container hundred_percent=”no” equal_height_columns=”no” menu_anchor=”” hide_on_mobile=”small-visibility,medium-visibility,large-visibility” class=”” id=”” background_color=”” background_image=”” background_position=”center center” background_repeat=”no-repeat” fade=”no” background_parallax=”none” parallax_speed=”0.3″ video_mp4=”” video_webm=”” video_ogv=”” video_url=”” video_aspect_ratio=”16:9″ video_loop=”yes” video_mute=”yes” overlay_color=”” video_preview_image=”” border_size=”” border_color=”” border_style=”solid” padding_top=”” padding_bottom=”” padding_left=”” padding_right=””][fusion_builder_row][fusion_builder_column type=”1_1″ layout=”1_1″ background_position=”left top” background_color=”” border_size=”” border_color=”” border_style=”solid” border_position=”all” spacing=”yes” background_image=”” background_repeat=”no-repeat” padding_top=”” padding_right=”” padding_bottom=”” padding_left=”” margin_top=”0px” margin_bottom=”0px” class=”” id=”” animation_type=”” animation_speed=”0.3″ animation_direction=”left” hide_on_mobile=”small-visibility,medium-visibility,large-visibility” […]

image for Celebrating Your IPO During a Pandemic

Celebrating Your IPO During a Pandemic

September 18, 2020 | Logistics, Investor Relations, IPO,

The process of an initial public offering typically requires tons of work and can take months or even years to complete. The day a company begins trading on a national stock exchange is a great reason to celebrate, and what better way to celebrate than ringing the opening or closing bell at the New York […]

image for Understanding the Importance of the NASDAQ Biotech Index (NBI)

Understanding the Importance of the NASDAQ Biotech Index (NBI)

September 11, 2020 | Investors, Investor Relations,

[fusion_builder_container hundred_percent=”no” equal_height_columns=”no” menu_anchor=”” hide_on_mobile=”small-visibility,medium-visibility,large-visibility” class=”” id=”” background_color=”” background_image=”” background_position=”center center” background_repeat=”no-repeat” fade=”no” background_parallax=”none” parallax_speed=”0.3″ video_mp4=”” video_webm=”” video_ogv=”” video_url=”” video_aspect_ratio=”16:9″ video_loop=”yes” video_mute=”yes” overlay_color=”” video_preview_image=”” border_size=”” border_color=”” border_style=”solid” padding_top=”” padding_bottom=”” padding_left=”” padding_right=””][fusion_builder_row][fusion_builder_column type=”1_1″ layout=”1_1″ background_position=”left top” background_color=”” border_size=”” border_color=”” border_style=”solid” border_position=”all” spacing=”yes” background_image=”” background_repeat=”no-repeat” padding_top=”” padding_right=”” padding_bottom=”” padding_left=”” margin_top=”0px” margin_bottom=”0px” class=”” id=”” animation_type=”” animation_speed=”0.3″ animation_direction=”left” hide_on_mobile=”small-visibility,medium-visibility,large-visibility” […]

image for Considerations if Your Company is Planning on Going Public Through a SPAC: Part 2

Considerations if Your Company is Planning on Going Public Through a SPAC: Part 2

September 4, 2020 | Investor Relations, IPO,

Positioning Your Company for Success Post SPAC or Reverse Merger When a company executes a reverse merger and/or becomes public via a Special Purpose Acquisition Company (SPAC) transaction, the newly public company will encounter investor relations challenges that differ from those of a traditional IPO. In Part II of our series, we will cover key […]

image for Considerations if Your Company is Planning on Going Public Through a SPAC: Part 1

Considerations if Your Company is Planning on Going Public Through a SPAC: Part 1

August 28, 2020 | Investor Relations, IPO,

Since January 2019, there have been about 15 US-listed SPAC IPOs compared to about 270 traditional IPOs. In our two-part series, we will explain the recent interest in SPACs and investor relations process and considerations. In Part I, we will cover how SPACs work and key transaction considerations. In Part II of our series, we […]

image for The Enduring Communications Playbook: How A Solid IR/PR Strategy Can Help Win Over Investors During Bull and Bear Markets

The Enduring Communications Playbook: How A Solid IR/PR Strategy Can Help Win Over Investors During Bull and Bear Markets

August 21, 2020 | Investor Relations, Guidance & Metrics, Messaging,

Strong investor relations and public relations strategies are core to building corporate visibility among investors of all sizes. Communications must ensure that key stakeholders are reached across a multitude of channels, whether one is preparing for a financing round or IPO as a private company or trying to attract additional audiences as a public company. […]

image for How Management Teams Establish Credibility

How Management Teams Establish Credibility

August 14, 2020 | Investor Relations, Guidance & Metrics, Messaging,

How do management teams establish credibility and become well-regarded by investors and sell side analysts? Summary Well-regarded management teams are generally characterized by their ability to establish credibility with investors and analysts. Credibility is earned through effective and balanced communication, rigorous financial planning, and the ability to respond to, and incorporate change into strategic planning. […]

image for Revisiting Your IR Calendar

Revisiting Your IR Calendar

August 7, 2020 | Investor Relations, Logistics, Conferences,

The COVID-19 pandemic has transformed the way we interact with everyone, including investors. Virtual meetings and conferences have become the new normal. While the personal, face-to-face conversations are missed, this format is likely to continue to some degree even after the current climate changes. Earlier in the pandemic, IHS Markit reported the results of a […]

image for S-1 Business Section Drafting 101

S-1 Business Section Drafting 101

July 31, 2020 | Presentation, Logistics, Strategy,

Pre-Org Meeting IPO Prep: S-1 Drafting The S-1 is comprised of business and financial information designed to inform prospective investors and outline all material business risks. It offers an in-depth, first look at a private company, and analysts and portfolio managers often comb through the public document carefully when considering an investment. General S-1 Drafting […]

image for 5 Things To Include In An IR Presentation

5 Things To Include In An IR Presentation

July 24, 2020 | Presentation, Investor Relations,

All companies, both public and private, will inevitably have to present their organization to investors. Though not every presentation is identical, there are some common topics that must be touched upon in every slide deck. Having worked on countless investor presentations for our clients, we have compiled a short list of what we believe should […]

image for What Makes an IR Website Best-In-Class?

What Makes an IR Website Best-In-Class?

July 17, 2020 | Presentation, Investor Relations,

Any company looking to attract market attention today should not underestimate the importance of a sophisticated corporate website with a high-quality investor relations section. We often tell clients that while a great website doesn’t make your company high-quality, all high-quality companies have great websites. Your website is often the very first place potential investors will look to […]

image for Re-engaging with Investors After a Setback

Re-engaging with Investors After a Setback

July 10, 2020 | Strategy, Messaging, Investor Relations,

Given the inherent scientific uncertainty in the drug development process, it is common for management teams to communicate equivocal or negative news to the investment community. Most seasoned biotech investors will say they make their investment decisions without a quarter to a third of the information they would like, and that the goal is to […]

image for The ABCs of VC/PE: PART 2 – INVESTOR TARGETING

The ABCs of VC/PE: PART 2 – INVESTOR TARGETING

June 26, 2020 | Investor Relations, Capital Raising,

When a company initiates a fundraising process or contemplates a sale, it can be difficult to identify appropriate firms to target, structure diligence items internally, and adequately prepare for the inevitable investor Q&A. After providing a general overview on Venture Capital and Private Equity in Part 1 of this series, we turn our attention to […]

image for IPO Timing Considerations

IPO Timing Considerations

June 19, 2020 | Strategy, IPO, Capital Raising,

During these unprecedented times, one recurring question we hear from private companies is whether to go public now or wait till markets and society normalize. Since markets are by nature dynamic and constantly changing, we italicize normalize to emphasize that everything appears chaotic when timelines are reduced. That is not to diminish the current environment, […]

image for Secondary Offerings In The COVID World

Secondary Offerings In The COVID World

June 12, 2020 | Strategy, IPO, Analysts,

With the COVID-19 pandemic continuing to overwhelm global economies and the uncertainty around the future and recovery timelines, many listed companies are recapitalizing through equity fundraising in the capital markets. Given the solid market recovery and valuations among med tech names, this has proven to be an opportunistic time for companies to finance. New equity […]

image for Analyst Education during Your IPO Process – Part II: Financial Diligence Meeting

Analyst Education during Your IPO Process – Part II: Financial Diligence Meeting

June 5, 2020 | Strategy, IPO, Analysts,

Initial public offerings (IPOs) are one of the most important milestones for many companies. During the IPO process, analysts are required to conduct formal diligence of the market opportunity, the unmet need, your company’s solution and your prospects for long term growth and business viability. Companies typically initiate this by hosting an Analyst Diligence meeting, […]

image for Analyst Education during Your IPO Process – Part I: Analyst Diligence Meeting

Analyst Education during Your IPO Process – Part I: Analyst Diligence Meeting

May 29, 2020 | Strategy, IPO, Analysts,

Initial public offerings (IPOs) are one of the most important milestones for many companies. During the IPO process, analysts are required to conduct formal diligence of the market opportunity, the unmet need, your company’s solution and your prospects for long-term growth and business viability. This is typically initiated with companies hosting an Analyst Diligence meeting, […]

image for Could J.P. Morgan’s 2021 Healthcare Conference Be Cancelled?

Could J.P. Morgan’s 2021 Healthcare Conference Be Cancelled?

May 22, 2020 | Investor Relations, Conferences, Strategy,

J.P. Morgan’s Annual Healthcare Conference is widely regarded as an unmissable event for industry executives, bankers, analysts, and private and public investors. However, despite being the largest healthcare investor conference, it is a fixture that many participants have mixed feelings about; it offers unrivaled access to investors and partners, but has been described at various […]

image for How To Make The Most Of 13F Filing Information

How To Make The Most Of 13F Filing Information

May 15, 2020 | Investors, Investor Relations,

Institutional investment managers with over $100 million in 13(f) securities that use the US mail or other means of interstate commerce are required to report their holdings as of the last day of each calendar quarter on SEC form 13F. Filings are due 45 days following the last day of the calendar quarter. This filing […]

image for Shareholder Rights Plans

Shareholder Rights Plans

May 1, 2020 | COVID-19, Strategy, Investors,

Following a company’s stock price being impacted by the COVID-19 pandemic, executive management teams should discuss any potential strategic implications on the company’s strategy with the board. As a result of a stock price dislocation driven by circumstances and factors outside the scope of management’s decision making, a company may become vulnerable to an undesired […]

image for Navigating Investor Meetings During A Crisis

Navigating Investor Meetings During A Crisis

April 24, 2020 | COVID-19, Logistics, Conferences, Investors,

Many aspects of the business world have been affected by the COVID-19 pandemic, and plans for investor interactions in 2020 is no exception. Planning for scheduled investor interactions, such as non-deal roadshows, generally takes place well in advance. This gives you time to reserve windows for travel during times when there are no quiet period […]

image for Virtual Annual Meetings

Virtual Annual Meetings

April 17, 2020 | Investor Relations, Presentation, COVID-19,

Annual meetings are a regulatory requirement for most public and private companies. While many retail investors may think a company’s annual shareholder meeting is like the extravaganza put together by Berkshire Hathaway, typical annual meetings are administrative and follow a specific format. Investors who own shares in a public company will receive a notification about […]

image for How is the Coronavirus Impacting Biotechs?

How is the Coronavirus Impacting Biotechs?

April 10, 2020 | Investor Relations, Strategy, COVID-19,

As the global number of confirmed COVID-19 cases soared past the one-million-mark last week, the United States has slowly climbed to the top of the list of most affected countries. While it is difficult to comprehensively detail the full breadth of the virus’ far-reaching consequences, this blog takes a look at the effect the pandemic […]

image for Guidance Considerations for COVID-19

Guidance Considerations for COVID-19

April 3, 2020 | Investor Relations, Guidance & Metrics, Messaging, COVID-19,

The everchanging news cycle has been accelerated with COVID-19 and the associated onset of daily, if not hourly, updates related to this global pandemic. Feeding into the news has been a set of dynamic considerations that are also continuously changing, such as COVID-19 testing details and evolving guidelines established at levels that stem from global […]

image for IR Considerations For Managing Your COVID-19 Response

IR Considerations For Managing Your COVID-19 Response

March 27, 2020 | Investor Relations, Guidance & Metrics, Messaging, COVID-19,

In many ways, a crisis such as COVID-19 demands immediate action. Since January, and particularly over the past few weeks, we have seen a tremendous mobilization of government and private resources in response to the novel coronavirus that has upended society and markets around the globe. This mobilization, along with the implementation of mitigation policies […]

image for The ABCs of VC/PE, Part 1

The ABCs of VC/PE, Part 1

February 28, 2020 | Investor Relations, Capital Raising,

Before a company initiates a fundraising process or contemplates a sale, it can be difficult to identify appropriate firms to target, structure diligence items internally, and adequately prepare for the inevitable investor Q&A. In the first part of this series we will provide a general overview on venture capital (VC) and private equity (PE). Our […]

image for Environmental, Social & Governance (ESG) Part 2: How To Get Started

Environmental, Social & Governance (ESG) Part 2: How To Get Started

February 21, 2020 | Guidance & Metrics, Messaging, Investor Relations,

In part two of our series on Environmental, Social, and Governance (ESG), we will explore ways to jump-start your company’s entrance into this new level of disclosure. There has been a lot of insightful information published on this topic, but many public companies are still left wondering the best, most comprehensive way to publicly disclose […]

image for Environmental, Social & Governance (ESG) Part 1: Landscape & Scores

Environmental, Social & Governance (ESG) Part 1: Landscape & Scores

February 14, 2020 | Guidance & Metrics, Investor Relations,

Environmental, Social, and Governance (ESG) considerations are becoming more relevant globally, and companies are now being evaluated on “non-financial” criteria alongside more traditional financial metrics. Changing priorities such as climate change and gender equality have become critical issues for the global community, including the investment landscape. As ESG metrics increase in importance, asset managers are […]

image for Five Ways Investor Relations Can Assist the Board of Directors

Five Ways Investor Relations Can Assist the Board of Directors

February 7, 2020 | Strategy, Investor Relations,

The investor relations team direct interactions with boards of directors are limited, but IR is a strong resource for the board in many situations. An integrated IR strategy with “boots on the ground” accumulates a wide variety of data from investors, sell-side analysts, bankers, lawyers, accountants, stock exchanges, corporate communications providers, and healthcare industry and […]

image for Which is Better for Development-stage Biotechs: IR or PR?

Which is Better for Development-stage Biotechs: IR or PR?

January 31, 2020 | Messaging, Strategy, Investor Relations,

A question I frequently get asked is this: As a development stage biotech, should I be engaging with a PR company or an IR company, and what is the difference? Let’s start with the latter first. What is the difference between IR and PR? Investor relations and public relations differ by virtue of their target […]

image for More Timing Considerations For Earnings Calls

More Timing Considerations For Earnings Calls

January 17, 2020 | Messaging, Strategy, Earnings,

In a 2017 blog titled Important Timing Considerations For Earnings Calls, we covered several things to keep in mind when scheduling quarterly earnings calls. In this blog we will review the quarterly reporting requirements and expand and look at a couple more considerations. An earnings call refers to the time when publicly-traded companies host a […]

image for Preannouncing At The JPM Conference

Preannouncing At The JPM Conference

December 20, 2019 | Guidance & Metrics, Strategy, Conferences,

“To pre-announce, or not to pre-announce, that is the question.” Next month marks the 38th year of the great pilgrimage to San Francisco. For five days every January, healthcare executives, investors, research analysts, bankers, and venture capitalists congregate in and around Union Square, searching for the next blockbuster company while trying to avoid a Theranos-like […]

image for Considerations for Visual Content in Investor Presentations

Considerations for Visual Content in Investor Presentations

December 13, 2019 | Presentation, Messaging,

It goes without saying that a compelling investor presentation deck can be a resourceful tool for providing a company’s value proposition. The visual content of the deck, in particular, plays an impactful role in the process of delivering this messaging. As Scott Berinato, a Senior Editor at Harvard Business Review, previously indicated, “A good visualization […]

image for Don’t Jump The Gun: Pre-IPO Considerations

Don’t Jump The Gun: Pre-IPO Considerations

December 6, 2019 | IPO, Capital Raising, Messaging,

With the right team in place, a compelling growth story, a comprehensive long-range plan, and a clear line of sight towards an IPO, executives become exceedingly proficient in marketing their company and its value proposition to a multitude of stakeholders. As they prepare for their organizational meeting and the official launch of the IPO process, […]

image for Hiring an Outside Writer for Your S-1

Hiring an Outside Writer for Your S-1

November 22, 2019 | Logistics, IPO,

One of the many decisions confronting a private company management when they begin contemplating accessing the public markets is how to write the S-1 document. The scope, complexity and legal requirements of the S-1 can make this process feel very daunting, particularly for managements who are undergoing it for the first time. And, while there […]

image for Financial Community Perception Surveys

Financial Community Perception Surveys

November 15, 2019 | Investor Relations, Analysts, Investors,

Is it time to consider a financial community perception survey? At some point in a public company’s lifespan, it’s prudent to consider conducting a formal survey of the financial community. The primary goal is to reach out to a targeted group of analysts and investors to identify how they currently perceive certain aspects of your […]

image for Valuable Lessons from WeWork and Other Unicorns

Valuable Lessons from WeWork and Other Unicorns

November 1, 2019 | Fundraising, Capital Raising, IPO,

Recent scandals among tech’s unicorns have turned investor attention to hypergiant funding and blitzscaling: Outcome Health faced an investor lawsuit regarding misleading claims; John Carreyou’s NYTimes bestseller “Bad Blood: Secrets and Lies in a Silicon Valley startup” centers around fraud charges faced by Theranos; and, most recently, WeWork has faced negative publicity for its IPO […]

image for IPO Lock-Ups and Early Releases

IPO Lock-Ups and Early Releases

October 25, 2019 | Investor Relations, Capital Raising, Investors,

When a company is about to go public, early investors anticipate the stock rising after the IPO, but they must also endure a mandatory waiting period called the lock-up period. This period keeps pre-IPO investors from immediately selling their stock. Why does this exist, how does it impact the stock and what are some of […]

image for A Guide to Rule 10b5-1 Plans

A Guide to Rule 10b5-1 Plans

October 18, 2019 | Investor Relations, Messaging, Logistics,

Insider trading restrictions can be a constant headache for companies and their executive officers. Executives who receive a significant portion of their compensation in the form of options, restricted stock, or stock grants have a continual need to sell stock. Yet Securities and Exchange Commission’s (SEC) regulations, company insider trading policies, and fears of allegations […]

image for Investor Relations Considerations for Biotechs Partnering with Big Pharma

Investor Relations Considerations for Biotechs Partnering with Big Pharma

October 11, 2019 | Investor Relations, Strategy, Messaging,

Public and private investors in biotechnology stocks always look for the third-party validation of a biotech’s claims and technology. Multiple parties can provide such endorsements, including marquee investors, the scientific conferences at which biotechs present, the journals in which preclinical and clinical data is published, the caliber of members on your board and, most importantly, […]

image for Setting Goals for the J.P. Morgan Healthcare Conference (2020)

Setting Goals for the J.P. Morgan Healthcare Conference (2020)

October 4, 2019 | Investor Relations, Conferences,

The largest annual healthcare investment conference is quickly approaching. In the third week of 2020, from January 13—16, over 40,000 professionals will congregate in San Francisco to discuss healthcare business and industry updates at the J.P. Morgan Healthcare Conference. Management teams of both private and public medtech, life science tools and diagnostics, pharmaceutical, biotech, distributors, […]

image for Quiet Period: What It Means for Public and Private Companies

Quiet Period: What It Means for Public and Private Companies

September 19, 2019 | Investor Relations, Messaging,

A quiet period is the period of time when company insiders are required to limit certain business-related communication with the public. During this time, communication is monitored and enforced by the US Securities and Exchange Commission (SEC). Quiet periods exist mainly to avoid selective disclosure of material non-public information and prevent an artificial increase in […]

image for Should All Companies Prepare Quarterly Earnings Slides?

Should All Companies Prepare Quarterly Earnings Slides?

September 13, 2019 | Earnings, Logistics,

As we have stated in multiple blogs, quarterly earnings calls are possibly the most important form of communication that companies have with the investment community. With the advent of Regulation Fair Disclosure (Reg FD), the earnings call is an ideal opportunity for management teams to avoid selective disclosure and provide company information to all investors […]

image for Insider Trading Basics

Insider Trading Basics

September 6, 2019 | Investor Relations,

Despite insider trading being more commonly associated with illicit activities, legally, company insiders can buy and sell their stock. Legal insider trading activity is often tracked and analyzed by investors to gain insight into the internal sentiment of a company, and the lawful buying and selling decisions made by a company’s top executives can influence […]

image for How To Communicate A CEO Transition

How To Communicate A CEO Transition

August 29, 2019 | Messaging, Investor Relations,

Nearly every company, no matter the size, will eventually face a CEO transition. In fact, according to a study by Challenger, Gray & Christmas, the oldest executive outplacement firm in the US,CEO turnovers in 2018 occurred at the highest rate since the Great Recession, with 1,452 CEO departures, up 25.2% year over year. From an IR perspective, […]

image for Managing Corporate Access as the Relationship between Investors and Investment Banks Evolves

Managing Corporate Access as the Relationship between Investors and Investment Banks Evolves

August 23, 2019 | Investors, Logistics, Investor Relations,

For years, a mutually beneficial relationship existed between corporate management teams, investment banks and the buy-side regarding corporate access as represented by non-deal roadshows (NDRs) and conferences. Now, like many elements of this relationship, the process is undergoing a major revision with implications for all relevant parties. For corporate management teams, the bottom line is […]

image for How To Prepare for a Short Attack

How To Prepare for a Short Attack

August 16, 2019 | Messaging, Investors,

Short attacks have the potential to do significant and long-term damage to a public company’s valuation. Unlike the typical investor, a short seller seeks to gain from the decline in a company’s stock price. While there is little you can do to completely protect your shares from such an attack, there are several things you […]

image for IPO Pricing and Shares Offered Dynamics

IPO Pricing and Shares Offered Dynamics

August 2, 2019 | Investors, Capital Raising, IPO,

Going public can be a daunting process, with multiple steps to take, decisions to make, and involvement from many constituents – management teams, boards of directors, investors, lawyers, bankers, and more. All these constituents have different opinions, objectives, and areas of expertise. The culmination of all of this is the pricing of the IPO which […]

image for MiFID II Implications

MiFID II Implications

July 26, 2019 | Investors, Analysts,

One of the largest global regulatory packages in the past ten years became effective on January 3, 2018. The European Union’s Markets in Financial Instruments Directive, more commonly known as MiFID II, originated from the European Commission and is meant to provide a European-wide legislative framework for regulating financial markets. The primary goals of MiFID […]

image for Financial Modeling for Biotechs

Financial Modeling for Biotechs

July 19, 2019 | Earnings, Guidance & Metrics,

The average publicly listed biotech generates neither profit nor revenue. As such, so-called “quarterly earnings” announcements are typically non-events. Instead, management teams use quarterly releases and occasional “earnings calls” to update The Street on strategic events or pipeline development. While other companies and their following analysts fret over sales growth, gross margins, and market penetration, […]

image for Earnings Video Conference Calls

Earnings Video Conference Calls

July 12, 2019 | Earnings, Logistics,

Must see T.V. – Thoughts on using video broadcasting for earnings conference calls Earnings calls are arguably the most important form of communication that companies have with the investment community. Investors expect management teams to discuss business updates and financial performance every 90 days. This is the best opportunity management teams have to broadly disseminate […]

image for Investor Targeting

Investor Targeting

June 21, 2019 | Strategy, Investors,

Introduction Getting in front of investors who are active in your sector but may not be familiar with your company should be a top priority for public company management teams. It is especially important for micro and small-cap growth companies who are not yet household names in the investor world to actively pursue this practice […]

image for Pros & Cons of Professionally Taping Your Roadshow

Pros & Cons of Professionally Taping Your Roadshow

June 14, 2019 | Presentation, IPO,

An Initial Public Offering or IPO is the process of selling new or existing securities to the public for the first time. The process of “going public” consists of many steps, culminating in the pricing and after-market stabilization by the underwriters. While every step in the process is imperative, the ability of management to “sell” […]

image for IR Communications for Private Companies

IR Communications for Private Companies

June 7, 2019 | Investors, Investor Relations,

A critical element in the foundation of any company is a solid investor relations (IR) strategy. Essential to this strategy is a structure that effectively drives IR communications that build and sustain confidence and ensure continuous support. Often discussions about IR programs are centered around public companies, but a strong IR communications strategy can be […]

image for Follow-On Offerings

Follow-On Offerings

May 31, 2019 | Fundraising, IPO,

In previous blogs we have covered some of the basics of IPOs, the Importance of ATM Financing for Biotechs and Shelf Registrations. Today we look at a few basics of a marketed follow-on offering. Marketed Follow-On A marketed follow-on is a publicly announced offering that may include a short roadshow. Unlike an IPO roadshow which […]

image for Engaging Hedge Funds

Engaging Hedge Funds

May 24, 2019 | Investors, Fundraising,

Hedge funds represent a substantial pool of potential capital to biotech management teams, but engaging with them can offer many challenges due to their varying structures and motivations.   Understanding the drivers of the decisions within this class of investors should aid in increasing management teams’ comfort level in dealing with them.  Two of the more […]

image for Internal Forecasts, Guidance and Consensus Considerations

Internal Forecasts, Guidance and Consensus Considerations

May 17, 2019 | Earnings, Guidance & Metrics,

At the start of each earnings cycle, one of the first places we look to begin preparations for quarterly reporting is the external consensus numbers (what Wall Street expectations are) and our client’s internal forecasts –for the current quarter, the upcoming quarter and the full year. Topline growth, gross margins, operating expenses, and net income […]

image for The Value of 13F Filings

The Value of 13F Filings

May 3, 2019 | Investor Relations, Investors,

Filed by institutional investment managers with at least $100 million in equity assets under management, SEC Form 13F is a quarterly report that must be completed no more than 45 days after the end of each quarter. The report discloses to the Securities and Exchange Commission (SEC) the U.S. equity holdings of each filing entity. […]

image for What is an ETF?

What is an ETF?

April 26, 2019 | Investor Relations, Investors,

What Is An ETF? An ETF, or an exchange-traded fund, represents a portfolio of securities from traditional investments such as stocks or bonds to alternative assets like commodities or currencies, which aims to track the performance of a specific market index. An ETF is bought and sold on a stock exchange, and just like a […]

image for The Importance of ATM Financing for Biotechs

The Importance of ATM Financing for Biotechs

April 19, 2019 | Fundraising, Strategy,

The story of a development-stage biotech company is one of almost continuous fund-raising. Why, you may ask? Well, in the absence of revenue, the expense of progressing a drug candidate through preclinical and then clinical studies falls squarely on a company’s shareholders and supporters. Once a biotech company is public however, the number of funding […]

image for What Is Reg FD and How Does it Impact Me?

What Is Reg FD and How Does it Impact Me?

April 12, 2019 | Investor Relations, Guidance & Metrics,

Regulation Fair Disclosure, better known as Reg FD, is a regulation on corporate communication promulgated by the SEC.  The regulation limits public companies from disclosing material nonpublic information to select members of the investment community.  This type of information must be broadly disseminated through broad, non-exclusionary, public distribution.  The purpose of Reg FD is to […]

image for Quarterly Earnings – Do We Really Need to Read The Script?

Quarterly Earnings – Do We Really Need to Read The Script?

April 5, 2019 | Earnings, Logistics,

As we think about best practices for earnings and quarterly reporting, we focus on the message in its totality and how to best prepare. This means the press release, scripted remarks, Q&A preparation, analyst after-call preparation, and slides (if relevant). We spend time reviewing perception, consensus expectations, specific analyst areas of focus, and competitive commentary […]

image for Investor Outreach: Keeping Up with a Changing Landscape

Investor Outreach: Keeping Up with a Changing Landscape

March 29, 2019 | Earnings, Messaging,

Marketing your company to investors can be extremely stressful and time consuming. Constant traveling to get your company in front of investors is not ideal, from both a budgetary and quality of life standpoint. That’s why it’s important to utilize the available tools and tricks of the ever-changing marketplace, which can help save your company […]

image for Quarterly Earnings Calls: To Prerecord or Not Prerecord

Quarterly Earnings Calls: To Prerecord or Not Prerecord

March 22, 2019 | Presentation, Logistics,

The United States Securities and Exchange Commission (SEC) requires that public companies, whose securities trade on an exchange in the U.S., file quarterly and annual financial reports. According to the National Investor Relations Institute (NIRI), a U.S.-based association of corporate officers and investor relations consultants, 92% of companies represented by their members conduct quarterly earnings […]

image for IPO Marketing, Pricing & Allocation Tips

IPO Marketing, Pricing & Allocation Tips

March 14, 2019 | Logistics, IPO,

You’ve spent the last 12 months preparing for your IPO and life as a public company, selected bankers, and have finally flipped your S-1 from confidential to public. But what’s next? As you prepare for your first salesforce in-house presentation, the roadshow, and ultimately the deal pricing, here are a few tips to keep in […]

image for Quarterly Earnings Calls: Key Components and Flow

Quarterly Earnings Calls: Key Components and Flow

March 8, 2019 | Earnings, Investor Relations,

Financial results announcements can have a meaningful impact on stock price and analysts’ sentiment, particularly for well-followed large caps and profile sector specific stocks. For publicly traded companies on major exchanges, the SEC requires a 10K (annual) or 10Q (quarterly) filing. But what adds color and context is the optional–yet highly used–conference call following the […]

image for Environmental, Social, and Governance (ESG) and Its Relationship to Sustainable Investing

Environmental, Social, and Governance (ESG) and Its Relationship to Sustainable Investing

March 1, 2019 | Investors,

The importance of Environmental, Social and Governance, or ESG, is on the rise. But do you know how ESG relates to corporate social responsibility, or what it means for companies? In this article, we’ll explain ESG and how you can leverage it for sustainable investing. Understanding ESG ESG is the systematic integration of non-financial factors […]

image for Stock Delisting

Stock Delisting

February 21, 2019 | Investor Relations, IPO,

Stock Delisting: A Summary In order for a company to be listed on a major stock exchange such as the New York Stock Exchange (NYSE) or the Nasdaq Stock Market, the company must meet and maintain several requirements.  These requirements exist to maintain the exchange’s reputation and set a quality standard for the companies that […]

image for Content of an Investor Relations Website

Content of an Investor Relations Website

February 15, 2019 | Investor Relations, Investors,

Many investors, both individual as well as institutional, use a company’s investor relations (IR) website as their source of primary information. An effective IR website helps generate interest and build an active shareholder base, which is achieved through the effective delivery and execution of targeted investor communications. Strong design, website practices, and meaningful content that […]

image for Are Reverse Mergers A Good Way for Biotechs to Go Public?

Are Reverse Mergers A Good Way for Biotechs to Go Public?

February 8, 2019 | Investor Relations, IPO,

In reality, some public companies fail. And in the world of biotechnology, failure is more frequent than in other industries where firms typically generate revenue and/or profits before seeking a stock exchange listing. As such, there always seem to be a slew of biotechs, usually after a negative data event has undermined the value of […]

image for Getting to Know the Stock Exchanges

Getting to Know the Stock Exchanges

January 25, 2019 | IPO, Investors,

A big decision companies make after deciding to go public is which exchange they use to list their stock.  The exchange acts as the market where stock is bought and sold by brokers and traders, and its primary function is to provide a place to sell stock, making it a liquid asset. This is accomplished […]

image for 2019 Medtech Outlook

2019 Medtech Outlook

January 4, 2019 | Analysts, Investors,

While the final three months of 2018 wiped out much of the gains created in the overall market in the first three quarters of the year, the average large cap medtech stock outperformed the S&P 500 for the fifth consecutive year. According to Bank of America Merrill Lynch, large cap medtech started 2018 at a […]

image for Family Offices

Family Offices

December 21, 2018 | Investors, Investor Relations,

Family offices. Suddenly, that term is showing up on a regular basis in the investment community as family offices are seen more and more regularly on company schedules for investor meetings at conferences, NDRs and other investor events. In fact, the popularity and presence of family offices has increased to a point where some have […]

image for Preparing Your 2019 IR Calendar

Preparing Your 2019 IR Calendar

December 7, 2018 | Strategy, Investor Relations,

‘Tis the season…yes, the one that comes around every year for preparing management’s calendar for the coming year. It may seem that pulling this together in one comprehensive, twelve-month calendar becomes as overwhelming as the holiday season. But, just like covering your gift-giving list, if you plan ahead, you can enter the new year with […]

image for Quarterly Earnings Calls: Planning & Preparation

Quarterly Earnings Calls: Planning & Preparation

November 30, 2018 | Earnings, Investor Relations,

Publicly-traded companies are required to report their financial results on a Form 10-Q no later than 45 days following the end of the quarter. Depending on the size and complexity of your company, you will likely also plan to issue an earnings press release and host a conference call around the same time. While there […]

image for Preparing for J.P. Morgan | Part II: Logistics and Packing

Preparing for J.P. Morgan | Part II: Logistics and Packing

November 23, 2018 | Conferences, Investor Relations,

Happy Thanksgiving!! Last week, we wrote a piece on planning ahead for the annual J.P. Morgan Healthcare Conference in San Francisco. Unsurprisingly, it addressed investor relations related topics. This week, we address some of the lighter, non-IR, areas around planning. Preparation here can have a surprisingly meaningful impact on the success of your week at […]

image for Preparing for J.P. Morgan | Part I: Strategy

Preparing for J.P. Morgan | Part I: Strategy

November 16, 2018 | Conferences, Strategy,

We have officially started planning for the annual J.P. Morgan Healthcare Conference in San Francisco which will run January 7-10, 2019. As with many of you, several of us at Gilmartin have been coming to San Francisco for the week of the J.P. Morgan conference longer than we care to admit. Whether this is your […]

image for Preparing for a Productive Investor Conference

Preparing for a Productive Investor Conference

November 9, 2018 | Conferences, Strategy,

Investor conferences provide a great opportunity for companies to increase their visibility among investors and Wall Street. Companies can use these events to attract new investors, deepen current investor relationships and build relationships with the sell-side. Typically, investor conferences are hosted by an investment bank at a hotel and consist of company presentations and one-on-one […]

image for Direct Listing IPO

Direct Listing IPO

November 2, 2018 | IPO, Strategy,

Direct Public Offerings, or Direct Listings, gained attention in the first half of 2018 when Spotify bypassed the traditional underwritten IPO to list their shares on the New York Stock Exchange (NYSE) through a NYSE Direct Floor Listing. While this remains a rare occurrence for U.S. based companies, in this post we look at the […]

image for Investor Presentation Best Practices

Investor Presentation Best Practices

October 26, 2018 | Investor Relations, Strategy,

We have created a myriad of investor presentations and slides, sat through countless investor meetings and attended numerous conference presentations. As we think about preparing for the annual J.P. Morgan conference in January – having a good investor deck is on the priority list. We have captured some of the most frequently asked questions, and […]

image for Corporate Presentation or Fireside Chat?

Corporate Presentation or Fireside Chat?

October 19, 2018 | Conferences, Investor Relations,

The main objective for most companies that participate in investment bank conferences is increasing their exposure to current and potential new shareholders. With more than 70 investment bank healthcare-specific conferences scheduled each year, companies have many opportunities to meet with investors. Over the past several years, many of these banking-sponsored investor conferences have given corporate […]

image for What is a Shelf Registration?

What is a Shelf Registration?

October 12, 2018 | Capital Raising, Strategy,

A shelf registration statement (or form S-3, in SEC terminology), is a flexible registration with the SEC that allows an issuer to essentially “pre-register securities” without a specified issuance date or terms. The issuer of a shelf registration is not required to specify the exact amount or offering price of each type of security in […]

image for Communicating A Shortfall

Communicating A Shortfall

October 5, 2018 | Strategy, Earnings,

All companies find a time when they need to deliver bad news – this could be on a myriad of topics: clinical trial data that falls short of expectations, litigation rulings that go the other way, product recalls, manufacturing problems, and many other possibilities. In addition, and what draws most attention on a quarterly basis, […]

image for The Long and The Short of Hedge Funds

The Long and The Short of Hedge Funds

September 13, 2018 | Investors, Investor Relations,

Introduction to Hedge Funds Hedge Funds often have a bad reputation of being short sellers and/or frequent traders, due to short-term outlooks. While this may be true for some funds, it is important to understand there are many different investing strategies for hedge funds, including those that take large positions to hold for an extended […]

image for Tips for Analyst and Investor Meetings

Tips for Analyst and Investor Meetings

September 6, 2018 | Investors, Analysts,

Things to Consider Before, During, and After Meetings with Wall Street A fundamental component of a proactive investor relations program includes regular outreach and meetings with sell-side analysts and investors. We recommend showing a public company plan to the investment community for 2-3 days at least once a quarter. Those meetings can take many forms, […]

image for Introduction to Dutch Auctions

Introduction to Dutch Auctions

August 31, 2018 | IPO, Investor Relations,

A Dutch auction, also called a reverse auction, is the process of selling goods through an auctioneer who offers prices starting above the expected purchase price and then lowers prices until a buyer makes a bid. If no buyers place a bid and the price drops to a predetermined reserve amount, then there is no […]

image for Crisis Communication: Tips and Approaches

Crisis Communication: Tips and Approaches

August 24, 2018 | Investor Relations, Strategy,

Nearly every organization will experience a crisis of some form within its lifetime. Lack of preparation for a crisis may result in an operational break down, confused and angry stakeholders, and an extended period to bring resolution to the issue. As a result, the financial and reputational impact of the crisis may be more severe. […]

image for What Is A Crossover Fund?

What Is A Crossover Fund?

August 17, 2018 | Investors, Strategy,

Crossover Funds: A Win-Win Scenario? A crossover fund is an investment fund that invests in both publicly-traded and privately-held companies. Crossover funds are designed to give investors the ability to invest in private companies without having to be a “qualified” investor or an investor in a venture capital fund. Mutual and hedge funds that invest […]

image for Why Does Trading Volume Matter?

Why Does Trading Volume Matter?

August 10, 2018 | Investor Relations, Investors,

Trading volume is the number of a security’s shares traded during a given period of time. Trading volume indicates the overall activity of a stock and its momentum, and it is an important technical indicator used by investors to look at stock trends. Volume gives investors an idea of the price action of a security […]

image for Introduction to Dark Pools

Introduction to Dark Pools

July 27, 2018 | Investor Relations, Investors,

What are “Dark Pools”? “Dark pools” or “Dark pools of liquidity,” popularized by Michael Lewis’ 2014 book “Flash Boys,” are private trading platforms that provide a platform for the anonymous trading of securities. In contrast to public exchanges such as the New York Stock Exchange (NYSE), dark pools are primarily used by institutional investors who […]

image for The Role of Investor Relations in Passive, Quant & Hybrid Funds

The Role of Investor Relations in Passive, Quant & Hybrid Funds

July 20, 2018 | Investor Relations,

Passively Managed Funds Usually, of the 25 holders in many companies, one or more are passively managed funds. Think of names like Dimensional Fund, Vanguard, and BNY Mellon. These institutions can own positions in many public companies, and in some cases, material positions. From an investor outreach, targeting and shareholder mix perspective, how should you […]

image for What is a Greenshoe?

What is a Greenshoe?

July 13, 2018 | Investor Relations, IPO,

The Over-Allotment Option, or Greenshoe (named after the first company to use the instrument), is an often-misunderstood device that gives underwriters the means to stabilize a company’s stock for up to 30 days after an IPO or Follow-On pricing. To help you understand the mechanics and purpose of the Over-Allotment Option, we are going to […]

image for The Importance of a Compelling Investor Deck

The Importance of a Compelling Investor Deck

June 29, 2018 | Strategy, Investor Relations,

A storyteller is one of the most critical roles for a private company executive. Before milestones have been reached and revenue earned, companies must sell potential investors on the dream of what they believe the future holds. The investor presentation is the vehicle to tell this story; therefore, it is critical that the investor deck […]

image for Monitoring Short Sellers

Monitoring Short Sellers

June 22, 2018 | Investor Relations, Investors,

A key discipline that investor relations professionals must actively develop is constantly monitoring investor sentiment, which is the overall attitude that investors have toward a particular market.  It is crucial to maintain a thorough understanding of sentiment because it will inform each component of your company’s investor relations activities, including company messaging in communications and […]

image for When Your S-1 Flips to Public from Confidential

When Your S-1 Flips to Public from Confidential

June 12, 2018 | Investor Relations, IPO,

Filing Form S-1 with the SEC Form S-1 is a filing with the Securities Exchange Commission (SEC) used by private companies planning to go public, and it is comprised of business and financial information. The S-1 offers an in-depth, first look at a private company, and analysts and portfolio managers often use it when making […]

image for Does the Timing of Your Press Release Matter?

Does the Timing of Your Press Release Matter?

June 7, 2018 | Investor Relations,

Press releases are an important component of any company’s investor relations program. We are often asked what, from an investor standpoint, is the best time to issue a press release? The truth is that there is no “magical time” when a press release will have the most (or least, depending on the nature of the […]

image for Why Does a Private Company Need Investor Relations?

Why Does a Private Company Need Investor Relations?

May 25, 2018 | Investor Relations,

Many private companies ponder if and when they will need an investor relations program. While it may seem like a non-essential service for a private company, partnering with the right IR firm can be a strategic way to begin educating the investment community on the investment opportunity with your brand, no matter what your exit […]

image for Managing the Press Release Process

Managing the Press Release Process

May 18, 2018 | Investor Relations, Logistics,

Press releases are an important component of any company’s investor relations program. They are a key method for companies to announce news to a variety of stakeholders. Creating and approving press releases can be an involved process that requires various resources and stages of internal and external approval. Managing this process is not a simple […]

image for What You Need to Know about the Russell Index Rebalancing

What You Need to Know about the Russell Index Rebalancing

May 11, 2018 | Investor Relations,

Every year, FTSE Russell creates a family of indexes, called the Russell Indexes, that measure the performance of broad segments of the US equity market. These indexes have become benchmarks for measuring the performance of investment strategies used by institutional investors and portfolio managers. The main Russell Indexes are the Russell 3000, 1000 and 2000. […]

image for Understanding Regulation FD

Understanding Regulation FD

May 4, 2018 | Investor Relations, IPO,

Regulation Fair Disclosure (Reg FD) Regulation FD prohibits companies from disclosing material nonpublic information to select analysts, institutional investors and others without making widespread public disclosure. The rule reflects the view that all investors should have equal access to a company’s material disclosures at the same time. Since its enactment in 2000, Reg FD has […]

image for What type of content do investors look for on your IR website?

What type of content do investors look for on your IR website?

April 27, 2018 | Strategy, Investor Relations,

The Investor Relations portion of your website is a critical part of an investor’s learning experience surrounding your company. Both potential and current investors use your IR website as a quick reference page for financial information or calendar notifications as well as a way to familiarize themselves with your company’s earnings history, board and management […]

image for Managing Q&As: How to handle a difficult investor question

Managing Q&As: How to handle a difficult investor question

April 20, 2018 | Analysts, Investor Relations,

When planning ahead for your quarterly earnings call, it is critical to spend time focusing on the Q&A portion of your presentation. Prepping for questions that investors will likely ask allows you to be prepared and to deliver concise, impactful responses. Preparing scripted answers for Q&A sessions begins with creating a list of questions that […]

image for How to Get the Most Out of Your Non-Deal Roadshow  

How to Get the Most Out of Your Non-Deal Roadshow  

April 5, 2018 | Analysts, Investor Relations,

The aim of a for-profit company, public or private, is to earn a profit through its operations. In a perfect world, stock returns of public, for-profit companies would be positively correlated with corporate fundamentals; unfortunately, equity markets are inefficient. Scheduling a non-deal roadshow (NDR) is one of the easiest ways for senior management to introduce […]

image for Tips for Planning a Successful Investor Day   

Tips for Planning a Successful Investor Day  

March 28, 2018 | Analysts, Strategy,

In order to set your company apart in the competitive investment capital environment, it is vital to plan and execute an effective investor day. Investor days allow you to stay top of mind and have regular and impactful contact with your analysts and investors. The ultimate goals of an investor day are to: Educate the […]

image for How to Write a Shareholder Letter

How to Write a Shareholder Letter

March 22, 2018 | Investor Relations, Strategy,

A shareholder letter is an opportunity for a CEO to directly communicate with shareholders and to clearly lay out his or her vision for the company, align employees and other stakeholders around that vision, and highlight its current progress toward long-term goals. In 2015, a NIRI report survey found that 88% of companies produce an […]

image for What to Consider in the 12 Months Prior to an IPO

What to Consider in the 12 Months Prior to an IPO

March 15, 2018 | IPO, Strategy,

The IPO process ramps up quickly. The 12 months before a company goes public is a period of increasing complexity that requires strong execution. We offer a framework of four broad areas to help you organize high-level goals and manage the ever-accelerating swirl of demands as you prepare for your IPO. Cultivate External Relationships Strong […]

image for The Relationship Between IR and PR

The Relationship Between IR and PR

March 9, 2018 | Investor Relations, Strategy,

Perhaps the overlap between investor relations and public relations seems obvious because both roles are key communication functions within a company. But what about the relationship between the two functions? Strong coordination of a public company’s image and messaging to investors and the public can help drive valuation, sales and overall image. In an ideal […]

image for How to Communicate a Management Transition to Your Investors

How to Communicate a Management Transition to Your Investors

February 28, 2018 | Investor Relations, Strategy,

Management changes, while inevitable for most companies, can be stressful for both employees and investors. Communicating the change and plan of action well is essential to managing how employees and investors will receive the news.  Management changes are not always planned, leaving some companies without the advantage of foresight; but having a thoughtful and strategic […]

image for What’s the consensus on guidance?

What’s the consensus on guidance?

February 22, 2018 | Investor Relations, Analysts,

Should we give guidance? With what metrics? At what interval? These are questions management companies often struggle with when it comes to how they want to manage the street’s expectations. The answers to these questions, like any other component of an investor relations strategy, are unique to each company. Establishing best practices when it comes […]

image for Preparing for an IPO? Considerations for Choosing Investment Bank Partners

Preparing for an IPO? Considerations for Choosing Investment Bank Partners

February 15, 2018 | Investor Relations, IPO,

Executing an initial public offering is one of the most important milestones for many companies. It is vital that you do your homework when considering which investment banks you will use when you are approaching an IPO, as well as acquisitions and additional capital raising events. This relationship can make or break the success of […]

image for Investment Banking and Industry Conferences: How to Maximize your Time and Get the Best Exposure

Investment Banking and Industry Conferences: How to Maximize your Time and Get the Best Exposure

February 8, 2018 | Conferences, Investor Relations,

When thinking about your investor relations plan in the new year, it is critical to allot time for both industry and investment banking conferences. Staying in front of your current investors is critical, and so is participating in 1-on-1 meetings where you can tell your story and meet with interested potential investors. These personal meetings […]

image for FAQs on How to Structure an Earnings Script

FAQs on How to Structure an Earnings Script

January 31, 2018 | Strategy, Earnings,

Collectively, we have written, edited and read hundreds – if not thousands – of earnings scripts. So, today we are highlighting some of our most frequently asked questions and sharing our best practices for earnings call scripts. How long should our prepared remarks be? Over the past few years, we have tracked word count from […]

image for 10 Ways to Improve the Quality of Your Webcasts and Extend Investor Reach

10 Ways to Improve the Quality of Your Webcasts and Extend Investor Reach

January 25, 2018 | Strategy, Earnings,

Webcasts of conference presentations and quarterly earnings calls have become a routine part of most public company IR programs. They offer a means for ensuring Reg FD compliance, extend the reach to those who can’t attend the event, reach investors in regions that aren’t on their regular NDR schedule, and provide a resource for new […]

image for Takeaways from J.P. Morgan’s 2018 Healthcare Conference

Takeaways from J.P. Morgan’s 2018 Healthcare Conference

January 18, 2018 | Conferences,

The J.P. Morgan Healthcare Conference continues to be the largest healthcare investment symposium, bringing together global industry leaders, emerging growth companies and multiple constituents from the investment community. It was raining again during this year’s conference, but overall sentiment was optimistic, due to the recently-passed tax reform, a series of positive pre-announcements and innovation across […]

image for How Social Media Benefits Investor Relations

How Social Media Benefits Investor Relations

January 11, 2018 | Investor Relations, Strategy,

According to Merriam-Webster, social media are forms of electronic communication (such as websites for social networking and microblogging) through which users create online communities to share  information, ideas, personal messages, and other content. Based on research conducted by Hootsuite, there were 3.03 billion active social media users as of October 2017. With such a vast amount of […]

image for What Your Company Needs to Know about Reverse Mergers

What Your Company Needs to Know about Reverse Mergers

January 4, 2018 | Investor Relations, Strategy,

What is a Reverse Merger? A reverse merger, the most common alternative form of a public offering, allows a privately-held company to go public by acquiring a controlling interest in and merging with an existing public company. The existing public company can be in the form of an operating public company or a “shell company,” […]

image for Four Keys to Attracting and Maintaining Sell-Side Coverage

Four Keys to Attracting and Maintaining Sell-Side Coverage

December 19, 2017 | Strategy, Analysts,

There are many factors that go into sell-side analysts’ decisions to pick up coverage on a stock. Some of the questions they will ask themselves include: How much trading volume does the stock have? Can I interest my buy-side clients in this company? Can I generate trading revenue for my bank? Is there a clear […]

image for Tips for Planning Your Investor Relations Strategy

Tips for Planning Your Investor Relations Strategy

December 6, 2017 | Strategy, Investor Relations,

We have spent considerable time determining best practices for planning annual investor relations (IR) activities. Our approach is holistic – we are strategic in how we determine annual goals for investor relations. First, we tie in IR activities to operational events and expected achievements or challenges. From there, we incorporate potential news flow with the […]

image for The Best Practices for Large Cap Financial Reporting

The Best Practices for Large Cap Financial Reporting

November 28, 2017 | Investor Relations, Strategy,

We recently conducted a case study examining the best practices of quarterly financial reporting communications on twelve large cap, med tech companies, including Medtronic, Abbott Laboratories, Boston Scientific and Zimmer Biomet, to name a few. Throughout the course of our study, we identified several important best practices. Earnings Advisory The most common way companies choose […]

image for How Many Sell-Side Analysts Should Your Company Have?

How Many Sell-Side Analysts Should Your Company Have?

November 16, 2017 | Investor Relations, Analysts,

What’s the right number of analysts for your company? Each public company is different, and so are the analysts and investment banks that cover them. Analysts cover stocks for a host of reasons, including institutional (client) interest, liquidity, perceived valuation, potential upside, and investment bank relationships. Based on these factors, large-cap companies typically have more […]

image for Things to Consider During Blackout and Quiet Periods

Things to Consider During Blackout and Quiet Periods

November 2, 2017 | Investor Relations, Strategy,

Amongst the many rules and considerations that surround investor relations disclosure and trading practices, blackout and quiet periods are very important policies to implement and understand. Blackout periods are legally-mandated timeframes when any corporate insider is forbidden to trade in the company’s securities.  These restrictions exist to help reduce the risk of insider trading by […]

image for Best Practices for Analyst Meetings

Best Practices for Analyst Meetings

October 24, 2017 | Analysts, Analyst Day,

There are a variety of options for a company when it comes to analyst and investor events – full or half-day meetings on a standalone basis, formal meetings at industry tradeshows, or smaller roundtable events. If orchestrated well, Analyst Meetings can effectively improve a company’s perception, increase Wall Street awareness and understanding, and generate investor […]

image for Preparing for Cyber Security and Data Breaches

Preparing for Cyber Security and Data Breaches

October 13, 2017 | Investor Relations, Strategy,

Failing to plan is planning to fail. We attended a NIRI-hosted panel on cyber security and data breach in San Francisco, and we have been contemplating the implications for our client companies. The panel was hosted by Brandie Claborn, VP of Global Corporate Communications at Intel Security and included Mike Piazza – Partner at DLA […]

image for Important Timing Considerations for Earnings Calls

Important Timing Considerations for Earnings Calls

September 29, 2017 | Strategy, Earnings,

Following the end of a quarter, depending on public float and certain exceptions following IPOs, the Securities and Exchange Commission (SEC) requires companies to file quarterly and annual results via the respective 10-Q or 10-K forms. Typically, companies have 35-45 days to report their quarterly results, and year-end results are due within 60-90 days. Companies […]

image for Uplisting to a National Exchange

Uplisting to a National Exchange

June 15, 2017 | IPO, Strategy,

Uplisting to a national exchange is an important goal for many small, over-the-counter (OTC) companies, but it is one that needs to be vetted thoroughly. There are several important considerations including cost, ongoing listing requirements, timing, and adequate preparation. Once your company is trading on a national exchange – either the NYSE or NASDAQ – […]

image for Attracting Analyst Coverage

Attracting Analyst Coverage

March 5, 2017 | Strategy, Analysts,

The environment for sell-side analyst coverage has changed over time, due to a growing number of boutique banks and fewer bulge bracket firms. In addition, with consolidation in the sell-side industry, many analysts are now covering upwards of 40 companies at a time, some with a large team co-covering stocks and others with very little […]

image for Takeaways from J.P. Morgan’s 2017 Healthcare Conference

Takeaways from J.P. Morgan’s 2017 Healthcare Conference

January 16, 2017 | Strategy, Conferences,

This year’s J.P. Morgan Healthcare Conference was similar to years past, bringing together global industry leaders, emerging growth companies, and multiple constituents from the investment community. Despite the torrential downpour on Tuesday, umbrellas turned inside out, and rain throughout the week, investors and executives had packed schedules of meetings, receptions, and events. The incoming presidential […]